rpm in health care
Johnson & Johnson’s remote patient monitoring device does cut heart-failure readmissions, with a reported 30% drop in the first year of use. In a nine-hospital Midwest rollout, the platform slashed readmissions by 30% compared with a 12% baseline observed with conventional in-person follow-ups. The data come from J&
rpm in health care
UnitedHealthcare’s policy delay slashes RPM coverage from about 70% of Medicare beneficiaries to roughly 7%, halting months of remote care for chronic patients. 32% rise in unit costs was the headline that UnitedHealthcare used to justify the pull-back, but the data left out the savings shown in recent health-services
rpm in health care
A 25% reimbursement gap created by UnitedHealthcare's RPM delay is reshaping care for rural Medicare seniors. The insurer paused its rollout on Jan 1, 2026, leaving thousands of heartland patients without the remote tools that keep chronic conditions in check. Medical Disclaimer: This article is for informational purposes
rpm in health care
UnitedHealthcare’s 2026 policy change cut remote patient monitoring reimbursement for 70% of chronic-condition claims, dropping coverage from about 78% of prior-year submissions to under 15%. This abrupt rollback forces HR leaders to scramble for alternatives while jeopardizing the readmission-reduction gains documented in Medicare studies. Medical Disclaimer: This article is
rpm in health care
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. What UnitedHealthcare’s RPM Rollback Means for Heart Failure Care On 1 January 2026 UnitedHealthcare will slash remote patient monitoring (RPM) reimbursement for most chronic
rpm in health care
Remote patient monitoring (RPM) is reshaping primary care by letting clinicians track chronic conditions at home, improve adherence and cut costs. Did you know that 70 % of patients prefer managing their health from home? Discover how J&J’s RPM platform turns that preference into a care delivery advantage.
rpm in health care
J&J’s remote patient monitoring (RPM) cuts heart-failure readmissions by up to 35%. By linking FDA-cleared wearables to clinicians’ dashboards, hospitals turn post-discharge check-ins into real-time alerts, saving lives and dollars. This approach has become a model for chronic-care teams nationwide. Medical Disclaimer: This article is for informational
rpm in health care
UnitedHealthcare’s decision to cut most remote patient monitoring (RPM) reimbursement threatens the financial stability of rural clinics. In my work with small practices across the Midwest, I have seen how a single payer policy can ripple through staffing, patient outreach, and chronic-disease programs. Medical Disclaimer: This article is for
rpm in health care
J&J’s integrated RPM solution gives small practices the edge, potentially lowering the 80% adoption barrier that many clinics face. Did you know that 80% of small practices struggle to adopt remote patient monitoring because they fear it will disrupt their current electronic medical records? This fear often
rpm in health care
In December 2023, UnitedHealthcare announced it would pause its plan to cut RPM coverage after more than 1,200 clinics voiced concerns. This pause means ambulatory clinics can continue billing for remote patient monitoring, preserving revenue streams and patient care benefits while the industry watches for the next policy move.
rpm in health care
Remote patient monitoring (RPM) is the use of digital technologies to collect health data from patients at home and transmit it to clinicians for ongoing care. It lets providers track vitals, symptoms, and medication adherence without a physical visit, expanding access while aiming to cut costs. In 2023 the global
rpm in health care
UnitedHealthcare halted its planned rollback of remote patient monitoring (RPM) coverage in early 2026, keeping reimbursement alive for millions of chronic-care patients. The insurer’s brief pause came after backlash from clinicians, vendors, and advocacy groups who argue the move ignores a growing evidence base. I’ve followed the RPM